The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.
Emerging molecular markers of cancer
Abstract
Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and molecular markers of malignant tumors have been integrated into clinical practice 5,6 , with the US Food and Drug Administration (FDA) providing approval for several companion diagnostic devices and nucleic acid-based tests 7,8 .”
From Multimodal biomedical AI (2022) · cites this paper as [5]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
Serial Analysis of Gene Expression
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,713
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Self-citationXu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
(1977) · PubMed · Cited by 1,801
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,615
Flagged first, then by citations
1 of the 100 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 656
Head and neck squamous cell carcinoma: optimizing the therapeutic index
Rosenthal, D. I., & Blanco, A. I. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.3.501 · Cited by 15
Ross, J. S. (2003) · American Journal of Clinical Pathology · doi:10.1309/6cq7-axq6-whhb-xuwh · Cited by 15
Consistent DNA Hypomethylations in Prostate Cancer
Araúzo-Bravo, M. J., Erichsen, L., Ott, P., Beermann, A., Sheikh, J., Daniela Gerovska, D., Thimm, C., Bendhack, M. L., & Santourlidis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010386 · Cited by 14
Chen, K. M., Stephen, J. K., Havard, S., Mahan, M., Divine, G., & Worsham, M. J. (2015) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.3393 · Cited by 14
Fasudil Suppresses Fibrosarcoma Growth by Stimulating Secretion of the Chemokine CXCL14/BRAK
Miyamoto, C., Maehata, Y., Ozawa, S., Ikoma, T., Kubota, E., Izukuri, K., Kato, Y., Hata, R., & Lee, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12177fp · Cited by 14
Proteomics and metabolomics in cancer drug development
D’Alessandro, A., & Zolla, L. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.840440 · Cited by 14
Multiple Genetic Loci Modulate Lung Adenocarcinoma Clinical Staging
Frullanti, E., Galvan, A., Falvella, F. S., Manenti, G., Colombo, F., Vannelli, A., Incarbone, M., Alloisio, M., Nosotti, M., Santambrogio, L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2394 · Cited by 14
Ahmed, A. E., Al-Jahdali, H. H., Alshukairi, A. N., Alaqeel, M., Siddiq, S. S., Alsaab, H. A., Sakr, E. A., Alyahya, H. A., Alandonisi, M. M., Subedar, A. T., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.03.005 · Cited by 14
Zhang, T., Qin, Y., Tan, T., & Lv, Y. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800390 · Cited by 14
Future challenges in head and neck cancer: From the bench to the bedside?
Calabrese, L. S., Ostuni, A., Ansarin, M., Giugliano, G., Maffini, F. A., Alterio, D., Rocca, M. C., Petralia, G., Bruschini, R., & Chiesa, F. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.11.001 · Cited by 14
CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients
Debouki-Joudi, S., Trifa, F., Khabir, A., Sellami‐Boudawara, T., Frikha, M., Daoud, J., & Mokdad‐Gargouri, R. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160005 · Cited by 14
Molecular Detection of Early-Stage Laryngopharyngeal Squamous Cell Carcinomas
Temam, S., Bénard, J., Dugas, C., Trassard, M., Gormally, E., Soria, J., Faivre, S. J., Luboinski, B., Marandas, P., Hainaut, P. L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1535 · Cited by 14
Inverse PCR-Based RFLP Scanning Identifies Low-Level Mutation Signatures in Colon Cells and Tumors
Liu, W., Kaur, M., Wang, G., Zhu, P., Zhang, Y., & Makrigiorgos, G. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3652 · Cited by 14
MIYAMOTO, C., Maehata, Y., MOTOHASHI, K., Ozawa, S., Ikoma, T., Hidaka, K., Wada-Takahashi, S., Takahashi, S., Yoshino, F., Yoshida, A., et al. (2014) · Biomedical Research · doi:10.2220/biomedres.35.381 · Cited by 13
DNA Methylation-Based Fecal Biomarkers for the Noninvasive Screening of GI Cancers
Goel, A. (2010) · Future Oncology · doi:10.2217/fon.10.9 · Cited by 13
Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma
Kim (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.918 · Cited by 13
Zvara, Á., Hackler, L., Nagy, B. Z., Micsík, T., & Puskás, L. G. (2002) · Pathology & Oncology Research · doi:10.1007/bf03036737 · Cited by 13
Jezkova, E., Kajo, K., Žúbor, P., Grendár, M., Malicherová, B., Mendelová, A., Dókuš, K., Lasabová, Z., Plank, L., & Danko, J. (2016) · Tumor Biology · doi:10.1007/s13277-016-5324-3 · Cited by 12
Biofluid-Based Circulating Tumor Molecules as Diagnostic Tools for Use in Personalized Medicine
Bahassi, Y. L. E. M. (2013) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000157 · Cited by 12
Waldman, S. A., & Terzic, A. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00067.x · Cited by 12
Biomarkers in Medicine: An Overview
Fathi, E., Mesbah‐Namin, S. A., & Farahzadi, R. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/6917 · Cited by 12
Molecular Screening Testing for Colorectal Cancer
Levin, B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0578 · Cited by 12
Isotachophoresis of nucleic acids in agarose gel rods
Kondratova, V. N., Botezatu, I. V., Shelepov, V. P., & Lichtenstein, A. V. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909110169 · Cited by 12
Zhao, Y., Su, K., Wang, G., Zhang, L., Zhang, J., Junpeng, L., & Guo, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-05756-5 · Cited by 12
The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers
Nakayama, R., Arikawa, K., & BHAWAL, U. K. (2017) · Journal of Cancer · doi:10.7150/jca.21169 · Cited by 12
Diagnostic model for pancreatic cancer using a multi-biomarker panel
Choi, Y. J., Yoon, W., Lee, A., Han, Y., Byun, Y., Kang, J. S., Kim, H., Kwon, W., Suh, Y., Kim, Y., et al. (2021) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2021.100.3.144 · Cited by 12
Armstrong, W. B., Taylor, T. H., & Meyskens, F. L. (2003) · PubMed · Cited by 12
Engineered multifunctional nanowires as novel biosensing tools for highly sensitive detection
Arora, P., Sindhu, A., Dilbaghi, N., & Chaudhury, A. (2012) · Applied Nanoscience · doi:10.1007/s13204-012-0142-4 · Cited by 12
Computational genes: a tool for molecular diagnosis and therapy of aberrant mutational phenotype
Martínez-Pérez, I., Zhang, G., Ignatova, Z., & Zimmermann, K.-H. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-365 · Cited by 12
Regulation of Chemokine Production via Oxidative Pathway in HeLa Cells
Kina, S., Nakasone, T., Takemoto, H., Matayoshi, A., Makishi, S., Sunagawa, N., Liang, F., Phonaphonh, T., & Sunakawa, H. (2009) · Mediators of Inflammation · doi:10.1155/2009/183760 · Cited by 12
Novel diagnostic biomarker for patients with Non-Hodgkin's Lymphoma by IgH gene rearrangement
Bo, J., Sun, L., Wang, W., Ma, C., Li, H., & Zhao, Y. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.157345 · Cited by 12
Trifa, F., Karray-Chouayekh, S., Jmaa, Z. B., Jmal, E., Khabir, A., Sellami‐Boudawara, T., Frikha, M., Daoud, J., & Mokdad‐Gargouri, R. (2013) · Medical Oncology · doi:10.1007/s12032-012-0418-2 · Cited by 11
Zheng, W., & He, L. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3834-1 · Cited by 11
Deng, Q., Su, B., Ji, X., Fang, Q., Zhou, S., & Zhou, C. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190258 · Cited by 11
Serum protein kinase Cα as a diagnostic biomarker of cancers
Kang, J., Mori, T., Kitazaki, H., Niidome, T., Takayama, K., Nakanishi, Y., & Katayama, Y. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130340 · Cited by 11
MTA1 downregulation inhibits malignant potential in a small cell lung cancer cell line
Xue, H., Wang, H., Liu, J., Liu, H., Li, C., Li, H., Lin, C., Zhan, Q., Zhao, Z., & Qian, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3671 · Cited by 11
Real-time telomerase assay of less-invasively collected esophageal cell samples
McGruder, B. M., Atha, D. H., Wang, W., Huppi, K. E., Wei, W.-Q., Abnet, C. C., Qiao, Y., Dawsey, S. M., Taylor, P. R., & Jakupciak, J. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.012 · Cited by 11
Probing Tumour Proteostasis and the UPR with Serum Markers
Galmiche, A., Sauzay, C., Houessinon, A., Chauffert, B., & Pluquet, O. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.04.004 · Cited by 11
Bracalente, C., Rinflerch, A., Ibañez, I. L., García, F. M., Volonteri, V. I., Galimberti, G. N., Klamt, F., & Durán, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25303 · Cited by 11
Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis
Fang, C., Wang, X., Guo, D., Fang, R., & Zhu, T. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/1367576 · Cited by 11
RetractedKondratova, V. N., Botezatu, I. V., Shelepov, V. P., & Lichtenstein, A. V. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.09.004 · Cited by 11
Genomic Alphabets of Saliva as a Biomarker in Oral Cancer
Kumar, T. M., & Govindraju, P. (2017) · Journal of Indian Academy of Oral Medicine and Radiology · doi:10.4103/jiaomr.jiaomr_90_16 · Cited by 11
Genetic Defects as Tumor Markers
Lichtenstein, A. V., & Potapova, G. I. (2003) · Molecular Biology · doi:10.1023/a:1023329201643 · Cited by 11
Standards for validation of cancer biomarkers
O’Connell, C. D., Atha, D. H., & Jakupciak, J. P. (2005) · Cancer Biomarkers · doi:10.3233/cbm-2005-14-506 · Cited by 11
Rothacker, J., Ramsay, R. G., Ciznadija, D., Gras, E., Neylon, C. B., Elwood, N. J., Bouchier‐Hayes, D. M., Gibbs, P., Rosenthal, M. A., & Nice, E. C. (2007) · Electrophoresis · doi:10.1002/elps.200600829 · Cited by 10
Expression of EMSY gene in sporadic ovarian cancer
Altınışık, J., Karateke, A., Çoksüer, H., Ulutin, T., & Buyru, N. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0116-0 · Cited by 10
Reumer, A., Maes, E., Mertens, I., Cho, W. C. S., Landuyt, B., Valkenborg, D., Schoofs, L., & Baggerman, G. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.905743 · Cited by 10
Biodetection using a ZnO nanorod-based microfluidic device with a concentration gradient generator
Xie, Y., Shi, Y., Xie, W., Chang, M.-J., Zhao, Z., & Li, X. (2020) · New Journal of Chemistry · doi:10.1039/d0nj00859a · Cited by 10
Muñoz-Antonia, T., Muro‐Cacho, C., Sharma, S., Cantor, A. B., & Bepler, G. (2007) · Cancer · doi:10.1002/cncr.22937 · Cited by 10
Incorporating monotonicity into the evaluation of a biomarker
Ghosh, D. (2006) · Biostatistics · doi:10.1093/biostatistics/kxl018 · Cited by 10
IRX1 hypomethylation in osteosarcoma metastasis
Lu, J., & Wang, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4696 · Cited by 10
Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection
Barker, P. E., & Murthy, M. (2009) · Biomarker Insights · doi:10.4137/bmi.s2253 · Cited by 9
A multicolor nano-immunosensor for the detection of multiple targets
Shi, M., Chen, J., Huang, Y. X., Hu, K., Zhao, S., Chen, Z., & Liang, H. (2013) · RSC Advances · doi:10.1039/c3ra41846d · Cited by 9
Danstrup, C. S., Marcussen, M., Pedersen, I. S., Jacobsen, H., Dybkær, K., & Gaihede, M. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244101 · Cited by 9
Mitsui, Y., Shiina, H., Hiraki, M., Arichi, N., Hiraoka, T., Sumura, M., Honda, S., Yasumoto, H., & Igawa, M. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0970 · Cited by 9
Son, S. J., & Lee, S. B. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.79 · Cited by 9
Nagasaka, T., Goel, A., Matsubara, N., & Tanaka, N. (2006) · PubMed · doi:10.18926/amo/30741 · Cited by 9
Beyond Genetics--The Emerging Role of Epigenetic Changes in Hematopoietic Malignancies
Galm, O., & Esteller, M. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04075 · Cited by 9
Uses of DNA Methylation in Cancer Diagnosis and Risk Assessment
Jerónimo, C., Henrique, R., & Sidransky, D. (2004) · CRC Press eBooks · doi:10.1201/9780203487013.ch2 · Cited by 9
Self-citationPrinciples of Cancer Prevention
Meyskens, F. L., & Tully, P. (2005) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2005.06.002 · Cited by 9
Detection of surgical margins in oral cavity cancer: the role of dynamic optical contrast imaging
Pellionisz, P. A., Badran, K. W., Grundfest, W. S., & John, M. A. S. (2018) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000444 · Cited by 8
McEvoy, M., Attia, J., Oldmeadow, C. J., Holliday, E. G., Smith, W. T., Mangoni, A. A., Peel, R., Hancock, S. J., Walker, M. M., & Talley, N. J. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12137 · Cited by 8
Liu, P., Wilson, P. J., Redquest, B., Keobouasone, S., & Manseau, M. (2024) · Molecular Ecology Resources · doi:10.1111/1755-0998.13929 · Cited by 8
Shim, U. J., Lee, I.-S., Kang, H. W., Kim, J., Kim, W. T., Kim, I. Y., Ryu, K. H., Choi, Y. H., Moon, S., Kim, Y., et al. (2013) · Korean journal of urology · doi:10.4111/kju.2013.54.9.631 · Cited by 8
Protein Thiols and Butryrylcholinestrase in Saliva of Oral Cancer Patients
Chianeh, Y. R., Manjunath, R., Prabhu, K., Fernandes, D., Vidyasagar, M. S., & Kamath, A. (2013) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-013-0352-x · Cited by 8
Kondratova, V. N., Serdyuk, O. I., Shelepov, V. P., Потапова, Г. И., & Владимирович, Л. А. (2005) · Doklady Biochemistry and Biophysics · doi:10.1007/s10628-005-0070-2 · Cited by 8
Methylation-Based Biomarkers for Early Detection of Urological Cancer
Henrique, R., Costa, V. L., & Jerónimo, C. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i4.10 · Cited by 8
History and Physical Examination, Screening and Diagnostic Testing
Eusterman, V. D. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.10.001 · Cited by 8
Protein functionalized micro hydrogel features for cell–surface interaction
Bhatnagar, P., Nixon, A. J., Kim, I., & Kameoka, J. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9167-6 · Cited by 8
Biomarkers of Exposure, Effect, and Susceptibility
Links, J. M., & Groopman, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00111-1 · Cited by 8
Aberrant Methylation in Promoters of GSTP1, p16, p14, and RASSF1A Genes in Smokers of North India
Deep, J. S., Sidhu, S., Chandel, A., Thapliyal, S., & Garg, C. (2012) · ISRN Pulmonology · doi:10.5402/2012/247631 · Cited by 8
Yang, B., Guo, Q., Wang, F., Cai, K., Bao, X., & Chu, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160375 · Cited by 8
Real-time telomerase activity measurements for detection of cancer
Jakupciak, J. P. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.745 · Cited by 8
Application of Proteomics in Cancer Study
Azodi, M. Z., Rezaei–Tavirani, M., Mortazavian, A. M., Vafaee, R., Zali, H., & Kashani, M. S. (2013) · Cited by 7
Identification of Frequent Differentially Methylated Region in Sporadic Bladder Cancers
Hasegawa, R., Fujiwara, K., Obinata, D., Kawashima, H., Shinojima, Y., Igarashi, J., Wang, X., Ghosh, S., Nagase, H., & Takahashi, S. (2014) · Urologia Internationalis · doi:10.1159/000365197 · Cited by 7
Assessing the clinical utility of genomic expression data across human cancers
Xu, X., Huang, L. F., Chan, C. H. T., Yu, T., Miao, R., & Liu, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10002 · Cited by 7
Tumor vaccine: current trends in antigen specific immunotherapy.
Baral, R. (2005) · PubMed · Cited by 7
Distinguishing lung tumours from normal lung based on a small set of genes
Dracheva, T., Philip, R., Xiao, W., Gee, A. G., McCarthy, J., Yang, P., Wang, Y., Dong, G., Yang, H., & Jen, J. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.10.025 · Cited by 7
Mining knowledge and data to discover intelligent molecular biomarkers: Prostate cancer i-Biomarkers
Floares, A. G., Bălăcescu, O., Floares, C., Bălăcescu, L., Popa, T., & Vermesan, O. (2010) · International Workshop on Soft Computing Applications (SOFA) · doi:10.1109/sofa.2010.5565613 · Cited by 6
The PP2A regulator IER5L supports prostate cancer progression
Crespo, J. R., Martín-Martín, N., Garcia‐Longarte, S., Corres-Mendizabal, J., Carlevaris, O., Astobiza, I., Zabala‐Letona, A., Guiu, M., Azkargorta, M., González-Lopez, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06907-z · Cited by 6
Follow-up tests to detect recurrent disease: Patient's reassurance or medical need?
Smith, I. E., & Schiavon, G. (2013) · The Breast · doi:10.1016/j.breast.2013.07.030 · Cited by 6
Park, Y., Ryu, B., Ki, S. J., Liang, X., & Kurabayashi, K. (2021) · Advanced Materials Interfaces · doi:10.1002/admi.202101291 · Cited by 6
Molecular Imaging: A Primer for Interventionalists and Imagers
Wang, D. S., Dake, M. D., Park, J. M., & Kuo, M. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.04.042 · Cited by 6
Graber, H. L., Abdi, R. M. A., Xu, Y., Asarian, A., Pappas, P. J., Dresner, L., Patel, N., Jagarlamundi, K., Solomon, W. B., & Barbour, R. L. (2015) · Medical Physics · doi:10.1118/1.4932220 · Cited by 7
Can Circulating MicroRNAs Become the Test of Choice for Colorectal Cancer?
Kawamura, M., Toiyama, Y., Tanaka, K., Inoue, Y., Mohri, Y., & Kusunoki, M. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0240-7 · Cited by 6
Hata, R. (2012) · ISRN Otolaryngology · doi:10.5402/2012/797619 · Cited by 6
Nanoparticle toxicity and cancer
Prevenslik, T. (2011) · Journal of Physics Conference Series · doi:10.1088/1742-6596/304/1/012054 · Cited by 6
Aberrant Promoter Hypermethylation of Tazarotine-Induced Gene 1 (TIG1) in Head and Neck Cancer
Tokumaru, Y., Yahata, Y., & Fujii, M. (2005) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.108.1152 · Cited by 6
EGFRandhTERTExpression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups
Cherneva, R. V., Georgiev, O. B., Dimova, I. I., Rukova, B. B., Petrov, D., & Toncheva, D. I. (2010) · Biomarkers in Cancer · doi:10.4137/bic.s3383 · Cited by 6
Zhu, Y., He, D., Hou, Z., Lan, M., Zhang, Y., & Wang, Q. (2025) · Advanced Science · doi:10.1002/advs.202502626 · Cited by 5
Clinical Trials in Cancer and Pharmacogenomics: A Critical Evaluation
Băianu, I. C. (2012) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000109 · Cited by 5
Electrochemiluminescent Biosensors: Neuroscience Applications
Forster, R. J., & Keyes, T. E. (2013) · Neuromethods · doi:10.1007/978-1-62703-370-1_16 · Cited by 5
Ibañez, I. L., Grings, F. M., Bracalente, C., Rinflerch, A., Volonteri, V. I., Castro, M. A. A., Klamt, F., & Durán, H. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152582 · Cited by 5
Haque, M. H., Islam, M. N., Islam, F., Gopalan, V., Nguyen, N., Lam, A. K.-Y., & Shiddiky, M. J. A. (2017) · Electroanalysis · doi:10.1002/elan.201700039 · Cited by 5
Shi, G., Sun, D., Wang, Z., Liu, X., Guo, J., Zhang, S., Zhao, Y., & Ai, J. (2022) · Horticulture Environment and Biotechnology · doi:10.1007/s13580-021-00414-2 · Cited by 5
SePaCS—a web-based application for classification of seroreactivity profiles
Keller, A., Comtesse, N., Ludwig, N., Meese, E. U., & Lenhof, H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm262 · Cited by 5
C, I. (2011) · InTech eBooks · doi:10.5772/18781 · Cited by 4
Longinotti, G., Ybarra, G., Vighi, S., Perandones, C., Montserrat, J. M., Yakisich, J. S., Grasselli, M., & Radrizzani, M. (2021) · Diagnostics · doi:10.3390/diagnostics11020171 · Cited by 4
Ck AE1/AE3 Tumor Marker Expression in SCC of Head and Neck
Khan, N. R. (2014) · Cell Biology Research & Therapy · doi:10.4172/2324-9293.1000109 · Cited by 4
Intelligent Clinical Decision Support Systems for Non-invasive Bladder Cancer Diagnosis
Floares, A. G., Floares, C., Vermesan, O., Popa, T., Williams, M. B., Ajibode, S., Liu, C., Lixia, D., Wang, J., Nicola, T., et al. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-21946-7_20 · Cited by 4
Metadata
- Authors
- Sidransky, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Sidransky, David
- ORCID
- Sidransky, David
- Venue
- Nature Reviews Cancer
- Published
- 2002-03
- Volume
- 2
- Issue
- 3
- Pages
- 210-219
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2010444010
- Cited by
- 662
- References
- 100
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 18 · 2016: 30 · 2015: 34 · 2014: 33 · 2013: 33 · 2012: 35
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- molecular markers, tumor markers, cancer detection, prognosis, disease progression monitoring, treatment response monitoring, gene expression changes, protein structure-function relationship, clinical implementation
- MeSH terms
- DNA, Genetic Markers, Humans, Mutation, Neoplasms, Sensitivity and Specificity, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review